Organon & Co. received an analyst rating update and filed with the SEC regarding institutional holdings.
1 report, 1 independent
Updated Sep 8
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Organon & Co. received an analyst rating update and filed with the SEC regarding institutional holdings.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Organon & Co.
pharmaceutical company
Nothing else this week.
-
SEC
Slovak company
Related events
- Cencora filed required disclosures regarding institutional ownership changes with the SEC and received analyst reports from Morgan Stanley.
- Analyst rating targets are affecting stock prices, and required reports regarding ownership stakes are being filed with the SEC for Bank of America and KBR, Inc.